Fleury S.A. (BVMF:FLRY3)

Market Cap	6.39B
Revenue (ttm)	7.55B
Net Income (ttm)	613.53M
Shares Out	544.28M
EPS (ttm)	1.16
PE Ratio	10.14
Forward PE	9.28
Dividend	0.70 (5.88%)
Ex-Dividend Date	Dec 16, 2024

Volume	2,918,800
Average Volume	3,231,505
Open	11.90
Previous Close	11.88
Day's Range	11.66 - 11.91
52-Week Range	11.21 - 16.87
Beta	0.62
RSI	46.20
Earnings Date	Feb 27, 2025

About Fleury

Fleury S.A., together with its subsidiaries, provides medical services in the diagnostic, treatment, clinical analysis, health management, medical care, orthopedics, and ophthalmology areas in Brazil. The company operates through three segments: Diagnostic Medicine, Integrated Medicine, and Dental. It provides laboratory and imaging tests, genomics, health management and platform, diagnostic information, check-up and reference laboratory, clinic day, infusion center, orthopedics and ophthalmology, dental imaging tests, and diagnostic imaging se...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1926
• Employees: 27,300
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: FLRY3

Financial Performance

In 2023, Fleury's revenue was 6.47 billion, an increase of 44.99% compared to the previous year's 4.46 billion. Earnings were 423.76 million, an increase of 37.62%.